Samsung Biologics Co.,Ltd.

207940.KS · Moat type: REGULIERUNG

MoatScore

9/10

Fair Value

749,578 KRW (≈ 524.70 USD)

Margin of Safety

-84.5 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Samsung Biologics is a South Korean Contract Development and Manufacturing Organization (CDMO) specialist that develops and manufactures biopharmaceuticals (antibodies, biosimilars, protein therapeutics) on a contract manufacturing basis for global pharmaceutical companies, thereby benefiting from long-term capacity contracts with fixed utilization dynamics.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.